GlassScriptPhysician profile
Andrew Pfaff
NPI 1831792977
$2,344.80
in general payments reported to CMS, 2019-2025
22 companies · $464 in 2025
The $464 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $704 · 2023: $1,001 · 2024: $176 · 2025: $464.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,641.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,640.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $522.21 | 2022-2025 | Xtampza |
| Abbvie INC. | $255.50 | 2023-2025 | |
| Medtronic, INC. | $240.51 | 2022-2025 | Intellis Adaptivestim |
| Grt US Holding, INC. | $161.11 | 2022 | |
| Averitas Pharma INC. | $153.06 | 2023-2024 | Qutenza |
| Vertos Medical, INC. | $118.62 | 2023 | Mild Device Kit |
| Globus Medical, INC. | $112.54 | 2025 | Senza |
| Fidia Pharma USA INC. | $101.15 | 2022-2025 | Hymovis |
| Idorsia Pharmaceuticals US INC | $93.74 | 2023 | Quviviq |
| Biohaven Pharmaceutical Holding Company LTD. | $78.00 | 2022 | |
| Boston Scientific Corporation | $77.84 | 2022-2023 | Wavewriter Alpha Prime 16 |
| Pfizer INC. | $62.85 | 2023 | |
| Azurity Pharmaceuticals, INC. | $56.91 | 2023 | Horizant |
| Relievant Medsystems, INC. | $51.56 | 2022 | |
| Bioventus LLC | $49.32 | 2022-2023 | Durolane |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $42.56 | 2023-2024 | Tirosint, Licart, Licart |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.15 | 2024-2025 | Relistor |
| Kowa Pharmaceuticals America, INC. | $33.42 | 2022-2023 | Seglentis |
| Hikma Pharmaceuticals USA | $29.24 | 2022 | |
| Lundbeck LLC | $24.31 | 2022 | |
| Spinal Simplicity, LLC | $22.76 | 2022 | |
| Saluda Medical Americas, INC. | $20.44 | 2025 | Evoke |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Pfaff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.